Nasdaq Rises Over 1%; US Inflation Rate Falls In June

U.S. stocks traded higher this morning, with the Nasdaq Composite surging over 1% on Wednesday. Following the market opening Wednesday, the Dow traded up 0.78% to 34,527.32 while the NASDAQ rose 1.18% to 13,922.99. The S&P 500, also rose, gaining, 0.88% to 4,478.36.

U.S. stocks traded higher this morning, with the Nasdaq Composite surging over 1% on Wednesday.

Following the market opening Wednesday, the Dow traded up 0.78% to 34,527.32 while the NASDAQ rose 1.18% to 13,922.99. The S&P 500, also rose, gaining, 0.88% to 4,478.36.

Check This Out: Halliburton, Signet Jewelers And 2 Other Stocks Insiders Are Selling

 

Leading and Lagging Sectors

  • Communication services shares climbed by 1.3% on Wednesday.
  • In trading on Wednesday, health care shares rose by just 0.03%.

 

Top Headline

The annual inflation rate in the U.S. eased to 3% in June, recording the lowest level since March 2021, versus May’s level of 4% and market expectations of 3.1%.

 

Equities Trading UP

  • Healthcare Triangle, Inc. (NASDAQ:HCTI) shares shot up 203% to $9.87 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.
  • Shares of Ault Alliance, Inc. (NYSE:AULT) got a boost, shooting 56% to $5.14 after the company said it anticipates $200 million in annual revenue for 2023.
  • Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) shares were also up, gaining 74% to $11.80 after the company announced collaboration and a $50 million investment from NVIDIA.

 

Equities Trading DOWN

  • CBL International Limited (NASDAQ:BANL) shares dropped 47% to $2.66 after jumping over 12% on Tuesday.
  • Shares of PainReform Ltd. (NASDAQ:PRFX) were down 42% to $9.53 after the company reported pricing of $2.7 million concurrent registered direct offering and private placement.
  • Katapult Holdings, Inc. (NASDAQ:KPLT) was down, falling 28% to $0.7099. Katapult’s board approved a 1-for-25 reverse stock split of common stock.

Also Check This Out: Top 5 Tech Stocks That May Fall Off A Cliff

 

Commodities

In commodity news, oil traded up 1.4% to $75.91 while gold traded up 1.2% at $ 1,959.80.

Silver traded up 3.7% to $24.15 on Wednesday while copper rose 1.6% to $3.8275.

 

Euro zone

European shares were higher today. The eurozone’s STOXX 600 rose 1.3%, London’s FTSE 100 rose 1.6% while Spain’s IBEX 35 Index gained 1% The German DAX gained 1.3% French CAC 40 climbed 1.3% and Italy’s FTSE MIB Index gained 1.4%.

Spain's annual consumer price inflation eased to 1.9% in June from 3.2% in May.

 

Asia Pacific Markets

Asian markets closed mostly lower on Wednesday, with Japan’s Nikkei 225 falling 0.81%, Hong Kong’s Hang Seng Index gaining 1.08%, China’s Shanghai Composite Index declining 0.78%. India’s S&P BSE Sensex fell 0.34%.

Producer prices in Japan increased by 4.1% year-over-year in June, slowing to their lowest level since April 2021. Japan's core machinery orders fell 7.6% month-over-month in May.

 

Economics

  • Mortgage applications in the U.S. rose 0.9% in the week ended July 7, 2023.
  • The annual inflation rate in the U.S. eased to 3% in June, recording the lowest level since March 2021, versus May’s level of 4% and market expectations of 3.1%.

Now Read This: These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts

 

COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 107,361,310 cases with around 1,168,530 deaths. India confirmed a total of at least 44,994,610 cases and 531,910 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 691,421,710 cases of COVID-19 worldwide with more than 6,898,950 deaths.

 

Total
0
Shares
Related Posts
Read More

NGM Bio Presents Updated Preliminary Findings From Ongoing Phase 1b Dose Escalation Trial Of NGM120 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Cancer At AACR Special Conference: Pancreatic Cancer

NGM120 is a novel antagonist antibody that binds GFRAL and inhibits GDF15 signaling for the potential treatment of cancer NGM120 has been well tolerated to date in patients in the Phase 1b combination cohort (NGM120 +

NGM